Effects of Domperidone on QT Interval in Children with Gastroesophageal Reflux Disease

Thitima Ngoenmak1, Suporn Treepongkaruna2, Yuthapong Buddharaksa3

  • 1Department of Pediatrics, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand; Department of Pediatrics, Faculty of Medicine, Naresuan University, Phitsanulok 65000, Thailand.

Insights

Domperidone use in children under two years old did not significantly prolong the corrected QT interval (QTc). However, two patients on domperidone and lansoprazole experienced QTc increases, suggesting caution with co-administration.

Area of Science:

  • Pediatric Cardiology
  • Pharmacology
  • Gastroenterology

Background:

  • Domperidone is frequently prescribed for gastroesophageal reflux disease (GERD) in pediatric patients.
  • Limited data exists on domperidone's impact on cardiac repolarization, specifically the corrected QT interval (QTc), in young children.
  • This study investigates the effect of domperidone on electrocardiogram (ECG) repolarization parameters in infants and toddlers.

Purpose of the Study:

  • To evaluate the short-term effects of oral domperidone on cardiac repolarization in children younger than two years.
  • To assess changes in corrected QT interval (QTc) and Tpeak to Tend (TpTe) interval following domperidone administration.
  • To determine if domperidone monotherapy necessitates routine ECG monitoring in this age group.

Main Methods:

  • Electrocardiograms (ECGs) were obtained from 22 children under two years of age before and after a minimum one-week course of oral domperidone (0.3 mg/kg three times daily).
  • Measurements included QT, RR, and Tpeak to Tend (TpTe) intervals to calculate QTc and the TpTe/QT ratio.
  • Statistical analysis compared pre- and post-treatment ECG parameters.

Main Results:

  • No significant difference was observed in the median QTc interval before and after domperidone treatment (p=0.159).
  • Two patients (9.1%) exhibited a QTc interval increase to ≥450 milliseconds, both of whom were receiving concomitant lansoprazole.
  • A significant decrease was noted in both the TpTe interval (p=0.001) and the TpTe/QT ratio (p=0.004) after domperidone administration.

Conclusions:

  • Short-term domperidone treatment in children under two years does not appear to significantly prolong the QTc interval.
  • Concomitant use of domperidone with lansoprazole may be associated with QTc prolongation in susceptible children.
  • Routine baseline and follow-up ECGs may not be essential for all children receiving domperidone monotherapy, but caution is advised with combination therapy.
Abstract

Related Concept Videos

Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists01:28

Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists

Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
1.8K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
824
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
776
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
346
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
486
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors01:13

Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors

Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
1.3K